Why the Biotech Sector Should Come Back First

The market has turned for the worst in recent weeks and continues to fall in a bear market fashion. 

Most of our portfolio strategies are holding more than 50% cash, some are utilizing inverse ETFs, and in my discretionary trading service, we are largely in cash. 

We are looking for profitable opportunities to deploy dry powder.

One of the areas we are watching is the biotech sector, represented above by the iShares Biotech ETF (IBB) or AKA “Big Brother.”

ibb biotech sector etf trading decline price analysis chart september

The biotech industry is often considered risky since biotech companies, especially in the small/micro-cap sector, are often speculative, and individual stocks can suffer vicious losses.

Yet, many areas of biotech show incredible promise, including regenerative medicine, gene therapy, genomics, new advances in treating cancer and autoimmune disorders, to name just a few. 

IBB should be on your shopping list for a few reasons.

1. (IBB) “Big Brother” is one of our Modern Family members and is trading well above the June lows while the indices tested them on Friday-we call that relative strength. 

2. Biotech received a $2 Billion Boost from the US government earlier this week.

  • One of the goals is cutting cancer deaths in half in the next 25 years.
  • The outcome of this government biotech initiative is unknown but can only be seen as a positive for the industry.  

3. IBB is sitting at an interesting pivotal support level  

  • IBB closed Friday over 115. 
  • Next key level to clear and give us a good risk point for entry is 118.

We are monitoring the biotech sector for a near-term rebound because of rising worldwide demand for medical advancements, aging populations, and new government backing for research. 

Mish’s Upcoming Seminars

ChartCon 2022 Stockcharts October 7-8th Seattle.

Join me and 16 other elite market experts for live trading rooms, fireside chats, and panel discussions

Stock Market ETFs Trading Analysis & Summary:

S&P 500 (SPY) At least held June lows for what’s it worth. 362 support and 371 resistance

Russell 2000 (IWM) Held June lows 163 support and resistance 170

Dow (DIA) Broke June lows-harbinger? Support at 292 and resistance at 300

Nasdaq (QQQ) Held June lows Support at 269 and resistance at 280

KRE (Regional Banks) Relative outperformer holding the 6-month calendar range high60 pivotal

SMH (Semiconductors) Held the 6-month calendar range low making 191 pivotal 

IYT (Transportation) Trans unhappy-unless Friday’s gap turns out an island bottom.

IBB (Biotechnology) 112 support and 118 resistance

XRT (Retail) Held the 6-month calendar range low Support at 55 and 60 resistance

Twitter: @marketminute

The author may have a position in mentioned securities at the time of publication. Any opinions expressed herein are solely those of the author and do not represent the views or opinions of any other person or entity.

Sign up for our FREE newsletter
and receive our best trading ideas and research